Omega Therapeutics Inc. is a developer of new methods of cancer treatment using genetics. All the company's developments are at the preclinical stage of testing.
Omega Therapeutics Inc— is OMEGA's proprietary software. This product helps to develop therapeutic agents for working with DNA and mRNA. The company's developments can be applied in the field of regenerative medicine, multigenic diseases: immunology, oncology, etc. The company has already investigated the effect of its drugs on hepatocellular carcinoma, non-small cell lung cancer and acute respiratory distress syndrome and received positive results.
Omega Therapeutics claims that they have deciphered the three-dimensional architecture of the human genome and accompanying regulators, which are organized into separate structures called IGD - isolated genomic domains.